Pembrolizumab, is an immunotherapy used to treat various cancers. Here are the key points:
Purpose and Mechanism:
- Pembrolizumab is an anti-PD-1 therapy that blocks the PD-1 receptor, allowing the immune system to recognize and attack cancer cells.
- It is used for several cancer types, including:
- Melanoma
- Lung cancer
- Head and neck cancer
- Hodgkin lymphoma
- Stomach cancer
- Cervical cancer
- Certain types of breast cancer.
Administration:
- Given as an intravenous infusion (IV) in a hospital or clinic.
- Typically administered every 3 to 6 weeks, depending on the specific cancer type and treatment plan.
Warnings and Side Effects:
- Pembrolizumab can cause serious side effects related to the immune system.
- Common side effects include skin problems, vision issues, fever, and muscle/joint pain.
- Frequent medical tests are necessary to monitor safety during treatment.
Remember to consult your doctor for personalized advice. If you have further questions, feel free to ask! 😊
Pembrolizumab
Strengths
25 mg/ml 4ml
Container
Glass Vial
Use
- It is used for several cancer types, including:
- Melanoma
- Lung cancer
- Head and neck cancer
- Hodgkin lymphoma
- Stomach cancer
- Cervical cancer
- Certain types of breast cancer.
- It is used for several cancer types, including:
Targate
PD-1